According to our new research study on “Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031-Global Analysis- by Delivery Mode, Application, End User, and Geography,” the market is anticipated to grow from US$ 843.77 million in 2023 and is projected to reach US$ 2.86 billion by 2031; it is expected to register a CAGR of 16.5% during 2023-2031.
The practice of outsourcing clinical studies with a massive rise in the number of trials and the flourishing pharmaceutical industry with a surge in research and development activities are contributing to the electronic patient-reported outcomes (ePROS) market growth. However, the data privacy and security issues hamper market growth. Further, the integration of artificial intelligence and machine learning with ePROS platforms is expected to bring new electronic patient-reported outcomes (ePROS) market trends in the coming years.
North America accounted for a major share of the global electronic patient-reported outcomes (ePROS) market in 2023. The North America electronic patient-reported outcomes (ePROS) market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices.
The increasing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation's alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a mainstay of high-quality and transformational cancer care and is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs.
Market players are taking electronic related patient outcomes (ePROS) market strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to amplify the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and increase in strategic initiatives by market players are expected to fuel the growth of the ePROs Market in the coming years.
The Canada electronic related patient outcomes (ePROS) market is driven by the rise in the adoption of digital health technologies and the increased use of wearables. The integration of technology in healthcare has resulted in the implementation of the electronic health record (EHR) and generated the demand for telehealth services. The government of Canada has taken initiatives to promote digital health technologies in the country.
For instance, in April 2018, under the "Regulatory Review of Drugs and Devices" initiative, the Health Canada founded a new division within the Therapeutic Products Directorate's Medical Devices Bureau, which allows more targeted pre-market evaluation of digital health technologies to adapt to fast changing technologies in digital health and respond to fast innovation cycles.
The increasing number of clinical trials in Canada has fueled the demand for ePROs to reduce the paperwork and increase efficiency with the help of technology. According to Innovative Medicines Canada, Canada accounts for the 3.1% in global clinical trials. Therefore, increasing adoption of digital health technologies and surging number of clinical trials have created a demand for ePROs for efficient monitoring of clinical trials driving the growth of electronic related patient outcomes (ePROS) market.
For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.
The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction.
With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and ClinicalTrials.gov are among the primary and secondary sources referred to while preparing the electronic patient-reported outcomes (ePROS) market report.
The practice of outsourcing clinical studies with a massive rise in the number of trials and the flourishing pharmaceutical industry with a surge in research and development activities are contributing to the electronic patient-reported outcomes (ePROS) market growth. However, the data privacy and security issues hamper market growth. Further, the integration of artificial intelligence and machine learning with ePROS platforms is expected to bring new electronic patient-reported outcomes (ePROS) market trends in the coming years.
North America accounted for a major share of the global electronic patient-reported outcomes (ePROS) market in 2023. The North America electronic patient-reported outcomes (ePROS) market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices.
The increasing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation's alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a mainstay of high-quality and transformational cancer care and is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs.
Market players are taking electronic related patient outcomes (ePROS) market strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to amplify the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and increase in strategic initiatives by market players are expected to fuel the growth of the ePROs Market in the coming years.
The Canada electronic related patient outcomes (ePROS) market is driven by the rise in the adoption of digital health technologies and the increased use of wearables. The integration of technology in healthcare has resulted in the implementation of the electronic health record (EHR) and generated the demand for telehealth services. The government of Canada has taken initiatives to promote digital health technologies in the country.
For instance, in April 2018, under the "Regulatory Review of Drugs and Devices" initiative, the Health Canada founded a new division within the Therapeutic Products Directorate's Medical Devices Bureau, which allows more targeted pre-market evaluation of digital health technologies to adapt to fast changing technologies in digital health and respond to fast innovation cycles.
The increasing number of clinical trials in Canada has fueled the demand for ePROs to reduce the paperwork and increase efficiency with the help of technology. According to Innovative Medicines Canada, Canada accounts for the 3.1% in global clinical trials. Therefore, increasing adoption of digital health technologies and surging number of clinical trials have created a demand for ePROs for efficient monitoring of clinical trials driving the growth of electronic related patient outcomes (ePROS) market.
Strategic Initiatives in Electronic Patient-Reported Outcomes (ePROS) to Provide Market Opportunities in Future
The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions.For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.
The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction.
With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs.
Electronic Patient-Reported Outcomes (ePROS) Market: Competitive Landscape and Key Developments
OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, and PatientIQ are among the key companies operating in the electronic patient-reported outcomes (ePROS) market.The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and ClinicalTrials.gov are among the primary and secondary sources referred to while preparing the electronic patient-reported outcomes (ePROS) market report.
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the electronic patient-reported outcomes (ePROS) market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the electronic patient-reported outcomes (ePROS) market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the electronic patient-reported outcomes (ePROS) market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Electronic Patient-Reported Outcomes (ePROS) Market Landscape
5. Electronic Patient-Reported Outcomes (ePROS) Market - Key Market Dynamics
6. Electronic Patient-Reported Outcomes (ePROS) Market - Global Market Analysis
7. Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by Delivery Mode
8. Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by Application
9. Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by End User
10. Electronic Patient-Reported Outcomes (ePROS) Market - Geographical Analysis
11. Electronic Patient-Reported Outcomes (ePROS) Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
The List of Companies - Electronic Patient-Reported Outcomes (ePROS) Market include:- OpenClinica LLC
- Buddy Healthcare Ltd Oy
- Castor
- Medable Inc
- Assistek
- Signant Health
- Crucial Data Solutions
- Curebase
- Y-Prime LLC
- Clinical Ink Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 149 |
| Published | October 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 843.77 Million |
| Forecasted Market Value ( USD | $ 2868 Million |
| Compound Annual Growth Rate | 16.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
